Author

Aaron Wise

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Accelerating Medicines Partnership: RA/SLE Network· 1 shared Adam T. Chicoine· 1 shared Alexander Yu RudenskyiD· 1 shared Ami Ben-Artzi· 1 shared Amit LakhanpaliD· 1 shared Andrew Cordle· 1 shared Andrew D. FileriD· 1 shared Arnon AraziiD· 1 shared

Activity by Year

2016-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Accelerating Medicines Partnership: RA/SLE Network

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SPP1hi macrophages in fibrin niches promote hyperplastic tissue remodeling in rheumatoid arthritis synovium

Ian Mantel, Haoxuan Zhang, Juan Vargas, Ce Gao, Hope A. Townsend, Richard D. Bell, Amit Lakhanpal, Miriam R. Fein, Accelerating Medicines Partnership: RA/SLE Network, Thomas M. Norman, Dana E. Orange, Daniel C. Ramirez, Edward F. DiCarlo, Susan M. Goodman, Melanie H. Smith, , Thomas Eisenhaure

SPP1hi macrophages in RA synovial fibrin deposits promote tissue hyperplasia.

Science Translational Medicine · Jun 24, 2026Peer-reviewedImmunology

Predicting Targeted Cancer Therapeutics

Aaron Wise, Murat Can Cobanoglu

This paper introduces an algorithmic ideation method that significantly improves hit discovery in drug development by predicting drug-target-disease associations more efficiently than traditional screening.

bioRxiv · Jun 8, 2016 · PreprintSystems Biology